← The Wire
TECXNasdaq
Tectonic Therapeutic, Inc.
Biological Products, (No Diagnostic Substances) · NY · CIK 1681087
Tectonic Therapeutic discovers and develops biologic medicines targeting GPCRs for unmet medical needs
red 8-K · 90d
$571M
Market cap
$33.09
Last close
+3.4%
1D
+9.1%
5D
257K
Volume
Price · last 39 sessions+11.6%
May 4L $26.87 · H $33.09Jun 29
201
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KShareholder Vote · Company UpdateJun 10, 20268-KResults of OperationsMay 7, 202610-Q10-QMay 7, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 20268-KExecutive Change · Reg FD DisclosureApr 23, 20268-KResults of OperationsFeb 26, 202610-K10-KFeb 26, 20268-KExecutive Change · Reg FD DisclosureFeb 24, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KCompany UpdateOct 30, 20258-KResults of Operations · Reg FD DisclosureAug 7, 202510-Q10-QAug 7, 2025424B5424B5Jun 11, 2025424B5424B5Jun 11, 20258-KShareholder VoteJun 6, 2025424B5424B5May 19, 2025424B5424B5May 19, 20258-KCompany UpdateMay 19, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 2025S-1S-1Mar 26, 202510-K10-KMar 20, 20258-KResults of OperationsMar 20, 2025424B5424B5Feb 12, 2025424B5424B5Feb 12, 20258-KMaterial Agreement · Equity IssuanceFeb 3, 20258-KReg FD Disclosure · Company UpdateJan 30, 20258-KReg FD DisclosureJan 13, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 7, 20248-KReg FD DisclosureSep 19, 20248-KResults of OperationsAug 14, 202410-Q10-QAug 14, 2024424B5424B5Jul 31, 20248-KReg FD Disclosure · Company UpdateJul 30, 2024S-1S-1Jul 19, 2024SC 13GSC 13GJul 10, 20248-KExecutive ChangeJul 5, 2024SC 13GSC 13GJul 1, 2024SC 13DSC 13DJun 27, 2024SC 13DSCHEDULE 13DJun 26, 20248-KReg FD Disclosure · Company UpdateJun 26, 2024SC 13DSC 13DJun 25, 20248-KAuditor Change · Change of ControlJun 20, 20248-K/ACompany UpdateJun 18, 20248-KCompany UpdateJun 14, 20248-KShareholder VoteJun 11, 2024425425Jun 4, 20248-KCompany UpdateJun 4, 2024425425Jun 3, 2024425425May 28, 2024425425May 21, 202410-Q10-QMay 9, 2024425425Apr 4, 202410-K10-KMar 14, 2024SC 13GSC 13GFeb 14, 2024S-4S-4Feb 14, 2024425425Jan 30, 2024425425Jan 30, 20248-KReg FD DisclosureJan 30, 2024425425Jan 30, 20248-KChange of Control · Executive ChangeJan 30, 202410-Q10-QNov 9, 202310-Q10-QAug 10, 2023SC 13GNONEJul 24, 20238-KExit / Disposal Costs · Reg FD DisclosureJul 12, 20238-K/AExit / Disposal CostsJun 14, 20238-KCompany UpdateJun 13, 20238-KExecutive Change · Agreement TerminatedJun 12, 20238-KExecutive Change · Shareholder VoteJun 9, 2023SC 13GSC 13GJun 6, 20238-KMaterial Agreement · Exit / Disposal CostsMay 22, 20238-KReg FD DisclosureMay 18, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEF 14ADEF 14AMay 1, 2023
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 6, 2026: 2 insiders bought $235K · 2 sold $567K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Ruddy Marcella K.Chief Medical Officer | Sell | 10,000 | $30.00 | $300K |
| Mar 6, 2026 | Mcnamara PeterChief Scientific Officer | Sell | 6,047 | $30.00 | $181K |
| Mar 6, 2026 | Mcnamara PeterChief Scientific Officer | Sell | 215 | $35.00 | $8K |
| Mar 4, 2026 | Mcnamara PeterChief Scientific Officer | Sell | 1,650 | $25.00 | $41K |
| Mar 3, 2026 | Mcnamara PeterChief Scientific Officer | Sell | 1,649 | $22.06 | $36K |
| Feb 11, 2026 | Reicin AliseChief Executive Officer | Buy | 2,500 | $21.10 | $53K |
| Feb 11, 2026 | Reicin AliseChief Executive Officer | Buy | 2,500 | $21.10 | $53K |
| Feb 10, 2026 | Lochner DanielChief Financial Officer | Buy | 6,000 | $21.61 | $130K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance